Table 2

Clinical characteristics of patients with deceased donor liver transplantation

CharacteristicsDonor with positive bacterial culturesP value
Group I: Yes, n=98Group II: No, n=187
Age, median (range)52 (33–65)48 (1–67)0.002
Sex (Male:Female)77:21132:550.160
Hepatitis status0.403
 Hepatitis B positive51 (52.0%)110 (58.8%)
 Hepatitis C positive21 (21.4%)27 (14.5%)
 Hepatitis B, C positive3 (3.1%)9 (4.8%)
 None23 (23.5%)41 (21.9%)
Comorbidity0.0414
 Diabetic mellitus13 (13.3%)14 (7.5%)
 Hypertension12 (12.2%)12 (6.4%)
 Chronic renal disease5 (5.1%)5 (2.7%)
 Heart disease3 (3.1%)0
 Others3 (3.1%)6 (3.2%)
 No72 (73.5%)157 (84.0%)
Indication of LT0.147
 Alcoholic Liver cirrhosis16 (16.3%)10 (5.4%)
 Virus-related liver cirrhosis40 (40.8%)98 (52.4%)
 Hepatocellular carcinoma32 (32.7%)46 (24.6%)
 Others10 (10.2%)33 (17.6%)
MELD score, median (range)21 (7–40)23 (7–40)0.673
Type of grafts0.0002
 Whole liver graft53 (54.1%)142 (75.9%)
 Partial liver graft*45 (45.9%)45 (24.1%)
Blood culture after LT (30 days)0.173
 Positive bacterial growth11 (11.2%)12 (6.4%)
 Negative bacterial growth87 (88.8%)175 (93.6%)
Patient outcomes0.849
 Hospital mortality (30 days)11 (11.2%)23 (12.3%)
  Graft dysfunction04 (2.1%)
  Postoperative haemorrhage2 (2.0%)5 (2.7%)
  Severe bacterial infections4 (4.1%)8 (4.3%)
  Acute rejections3 (3.1%)4 (2.1%)
  Others2 (2.0%)2 (1.1%)
 Death30 (30.6%)62 (33.2%)
 Alive57 (58.2%)102 (54.5%)
  • *Partial liver grafts included split liver and reduced-size liver grafts.

  • LT, liver transplantation; MELD, Model for End-stage Liver Disease.